WO2008093655A1 - ポリアルコール化合物および医薬 - Google Patents
ポリアルコール化合物および医薬 Download PDFInfo
- Publication number
- WO2008093655A1 WO2008093655A1 PCT/JP2008/051251 JP2008051251W WO2008093655A1 WO 2008093655 A1 WO2008093655 A1 WO 2008093655A1 JP 2008051251 W JP2008051251 W JP 2008051251W WO 2008093655 A1 WO2008093655 A1 WO 2008093655A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- polyalcohol
- polyalcohol compound
- pharmaceutical agent
- antihyperlipidemic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/16—Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
- C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Abstract
本発明は、水溶性が高く製剤化が容易である上に、必要な服用量を低減することができる抗高脂血症薬の有効成分になり得るポリアルコール化合物を提供することを目的とする。本発明のポリアルコール化合物は、下記式(I)で表される。 [式中、Rは、フィブラート系抗高脂血症化合物のうちカルボキシル基またはエステル基を除いた残基を示す。Xは、n個のポリアルコール部分をRに結合させるための結合基を示す。nは1~8の整数を示す。]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008556097A JPWO2008093655A1 (ja) | 2007-01-30 | 2008-01-29 | ポリアルコール化合物および医薬 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007020062 | 2007-01-30 | ||
JP2007-020062 | 2007-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008093655A1 true WO2008093655A1 (ja) | 2008-08-07 |
Family
ID=39673965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/051251 WO2008093655A1 (ja) | 2007-01-30 | 2008-01-29 | ポリアルコール化合物および医薬 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2008093655A1 (ja) |
WO (1) | WO2008093655A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
EP2567959A1 (en) | 2011-09-12 | 2013-03-13 | Sanofi | 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013035899A1 (ko) * | 2011-09-07 | 2013-03-14 | 주식회사 코리아테크노에이전시 | 5-히드록시-1, 3-디옥산의 제조 방법 및 이를 원료로 한 분기형 글리세롤 3량체의 제조 방법 |
WO2014141578A1 (ja) * | 2013-03-15 | 2014-09-18 | 信越化学工業株式会社 | 対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法 |
WO2020255741A1 (ja) * | 2019-06-17 | 2020-12-24 | 有限会社ケミカル電子 | 親水性金属表面処理剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005023844A1 (ja) * | 2003-09-03 | 2005-03-17 | Kyowa Hakko Kogyo Co., Ltd. | グリセロール誘導体で修飾された化合物 |
JP2006273849A (ja) * | 2005-03-02 | 2006-10-12 | Aska Pharmaceutical Co Ltd | フェノフィブラート含有組成物 |
-
2008
- 2008-01-29 WO PCT/JP2008/051251 patent/WO2008093655A1/ja active Application Filing
- 2008-01-29 JP JP2008556097A patent/JPWO2008093655A1/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005023844A1 (ja) * | 2003-09-03 | 2005-03-17 | Kyowa Hakko Kogyo Co., Ltd. | グリセロール誘導体で修飾された化合物 |
JP2006273849A (ja) * | 2005-03-02 | 2006-10-12 | Aska Pharmaceutical Co Ltd | フェノフィブラート含有組成物 |
Non-Patent Citations (1)
Title |
---|
WATANABE T. ET AL.: "Studies of Hypolipidemic Agents. 1. Synthesis and Hypolipidemic Activities of Alkoxycinnamic Acid Derivatives", JOURNAL OF MEDICINAL CHEMISTRY, vol. 23, no. 1, 1980, pages 50 - 59, XP001007865 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
WO2013035899A1 (ko) * | 2011-09-07 | 2013-03-14 | 주식회사 코리아테크노에이전시 | 5-히드록시-1, 3-디옥산의 제조 방법 및 이를 원료로 한 분기형 글리세롤 3량체의 제조 방법 |
EP2567959A1 (en) | 2011-09-12 | 2013-03-13 | Sanofi | 6-(4-Hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2014141578A1 (ja) * | 2013-03-15 | 2014-09-18 | 信越化学工業株式会社 | 対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法 |
JP2014198703A (ja) * | 2013-03-15 | 2014-10-23 | 信越化学工業株式会社 | 対称ハイパーブランチ型シリコーン変性重合性化合物、及びそのモジュール化した製造方法 |
US9428527B2 (en) | 2013-03-15 | 2016-08-30 | Shin-Etsu Chemical Co., Ltd. | Symmetric hyperbranched type silicone-modified polymerizable compound, and its modularized preparation method |
WO2020255741A1 (ja) * | 2019-06-17 | 2020-12-24 | 有限会社ケミカル電子 | 親水性金属表面処理剤 |
TWI728843B (zh) * | 2019-06-17 | 2021-05-21 | 日商化學電子有限公司 | 親水性金屬表面處理劑、將金屬的表面加以處理之方法、保護分支型甘油衍生物、以及用以製造保護分支型甘油衍生物之方法 |
US11124881B2 (en) | 2019-06-17 | 2021-09-21 | Chemical Denshi Co., Ltd. | Hydrophilic metal surface treatment agent |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008093655A1 (ja) | 2010-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008005511A8 (en) | Novel inhibitors of hepatitis c virus replication | |
WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
WO2007015824A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
WO2008137779A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
UA94052C2 (uk) | Похідні піридазину | |
AU2003273413A1 (en) | Pharmaceutically active oligosaccharide conjugates | |
WO2008021927A3 (en) | Hepatitis c virus inhibitors | |
MY149181A (en) | Isoxazoline derivative and preparation process thereof | |
WO2007140332A3 (en) | Low odor, low volatility solvent for agricultural chemicals | |
WO2008022006A3 (en) | Arylalkoxyl hepatitis c virus protease inhibitors | |
WO2008021871A3 (en) | Triazolyl acyclic hepatitis c serine protease inhibitors | |
WO2010139656A3 (en) | Synergistic fungicidal mixtures | |
WO2008019289A3 (en) | Tetrazolyl macrocyclic hepatitis c serine protease inhibitors | |
WO2008002924A3 (en) | Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors | |
WO2006010546A3 (en) | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors | |
WO2009076166A3 (en) | Oximyl hcv serine protease inhibitors | |
WO2008021733A3 (en) | Tetrazolyl acyclic hepatitis c serine protease inhibitors | |
WO2009053828A3 (en) | P3 hydroxyamino macrocyclic hepatitis c serine protease inhibitors | |
WO2008019266A3 (en) | Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors | |
WO2008093655A1 (ja) | ポリアルコール化合物および医薬 | |
MX2010005824A (es) | Derivados de aminotiazol. | |
TN2012000246A1 (en) | Pharmaceutical compositions comprising sigma receptor ligands | |
WO2009134616A3 (en) | Novel inhibitors of hepatitis c virus replication | |
EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
WO2009068468A3 (en) | Pyridine compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08710598 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2008556097 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08710598 Country of ref document: EP Kind code of ref document: A1 |